{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:31Z","timestamp":1786993111469,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.josat.2025.209633","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T19:25:19Z","timestamp":1737746719000},"page":"209633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Different forms of stigma and rural primary care professionals' willingness to prescribe buprenorphine"],"prefix":"10.1016","volume":"171","author":[{"given":"Berkeley","family":"Franz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay Y.","family":"Dhanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Bogart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyenne","family":"Fenstemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Trent","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209633_bb0005","doi-asserted-by":"crossref","first-page":"108923","DOI":"10.1016\/j.jsat.2022.108923","article-title":"National trends in buprenorphine prescribing before and during the COVID-19 pandemic","volume":"144","author":"Ali","year":"2023","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2025.209633_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/08897077.2019.1640833","article-title":"Underutilization of medications to treat opioid use disorder: What role does stigma play?","volume":"40","author":"Allen","year":"2019","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/08964289.2018.1555129","article-title":"Substance use stigma, primary care, and the New York state prescription drug monitoring program","volume":"46","author":"Allen","year":"2020","journal-title":"Behavioral Medicine"},{"key":"10.1016\/j.josat.2025.209633_bb0020","author":"Allport"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/jrh.12569","article-title":"Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder","volume":"38","author":"Andrilla","year":"2022","journal-title":"The Journal of Rural Health"},{"issue":"4","key":"10.1016\/j.josat.2025.209633_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1370\/afm.2099","article-title":"Barriers rural physicians face prescribing buprenorphine for opioid use disorder","volume":"15","author":"Andrilla","year":"2017","journal-title":"Annals of Family Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jrh.12307","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update","volume":"35","author":"Andrilla","year":"2019","journal-title":"The Journal of Rural Health"},{"key":"10.1016\/j.josat.2025.209633_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.abrep.2024.100541","article-title":"Addressing rural and non-rural substance use disorder stigma: Evidence from a national randomized controlled trial","volume":"19","author":"Ashworth","year":"2024","journal-title":"Addictive Behaviors Reports"},{"key":"10.1016\/j.josat.2025.209633_bb0045","author":"ASPE"},{"issue":"12","key":"10.1016\/j.josat.2025.209633_bb0050","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cptl.2022.10.002","article-title":"Contact based intervention reduces stigma among pharmacy students","volume":"14","author":"Bakos-Block","year":"2022","journal-title":"Currents in Pharmacy Teaching & Learning"},{"key":"10.1016\/j.josat.2025.209633_bb0055","series-title":"Constructing grounded theory: A practical guide through qualitative","volume":"379","author":"Charmaz","year":"2014"},{"key":"10.1016\/j.josat.2025.209633_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S304566","article-title":"The impact of stigma on people with opioid use disorder, opioid treatment, and policy","volume":"13","author":"Cheetham","year":"2022","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"11","key":"10.1016\/j.josat.2025.209633_bb0065","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1073\/pnas.1320901111","article-title":"Contextual effect of positive intergroup contact on outgroup prejudice","volume":"111","author":"Christ","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"16","key":"10.1016\/j.josat.2025.209633_bb0070","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1056\/NEJMc2312906","article-title":"Buprenorphine dispensing after elimination of the waiver requirement","volume":"390","author":"Chua","year":"2024","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2025.209633_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102701","article-title":"Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky","volume":"85","author":"Cooper","year":"2020","journal-title":"The International Journal on Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2025.209633_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1468017308101818","article-title":"The public stigma of mental illness and drug addiction","volume":"9","author":"Corrigan","year":"2009","journal-title":"Journal of Social Work"},{"key":"10.1016\/j.josat.2025.209633_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S183252","article-title":"The association between perceived stigma and substance use disorder treatment outcomes: A review","volume":"10","author":"Crapanzano","year":"2019","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2025.209633_bb0090","series-title":"Version 9.0.17, cloud application for managing, analyzing, and presenting qualitative and mixed method research data","author":"Dedoose","year":"2021"},{"key":"10.1016\/j.josat.2025.209633_bb0095","article-title":"\u201cYou\u2019re not supposed to be on it forever\u201d: Medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids","volume":"16","author":"Dickson-Gomez","year":"2022","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1016\/j.josat.2025.209633_bb0100","article-title":"Opioid use disorder","author":"Dydyk","year":"2023","journal-title":"StatPearls"},{"issue":"5","key":"10.1016\/j.josat.2025.209633_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/00952990.2015.1059842","article-title":"Rural substance use treatment centers in the United States: An assessment of treatment quality by location","volume":"41","author":"Edmond","year":"2015","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2025.209633_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/jrh.12832","article-title":"Primary care professionals\u2019 perspectives on tailoring buprenorphine training for rural practice","author":"Fenstemaker","year":"2024","journal-title":"The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association."},{"issue":"5","key":"10.1016\/j.josat.2025.209633_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15288\/jsad.2017.78.735","article-title":"Promoting adoption of medication for opioid and alcohol use disorders through system change","volume":"78","author":"Ford","year":"2017","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.josat.2025.209633_bb0120","doi-asserted-by":"crossref","first-page":"209280","DOI":"10.1016\/j.josat.2023.209280","article-title":"Rural-urban disparities in the availability of hospital-based screening, medications for opioid use disorder, and addiction consult services","volume":"160","author":"Franz","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2025.209633_bb0125","author":"GAO-04-110"},{"key":"10.1016\/j.josat.2025.209633_bb0130","doi-asserted-by":"crossref","DOI":"10.4324\/9780203793206-1","article-title":"Discovery of grounded theory: Strategies for qualitative research","volume":"1\u2013271","author":"Glaser","year":"2017","journal-title":"Discovery of Grounded Theory: Strategies for Qualitative Research"},{"key":"10.1016\/j.josat.2025.209633_bb0135","series-title":"Stigma; notes on the management of spoiled identity","author":"Goffman","year":"1963"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1214\/aoms\/1177705148","article-title":"Snowball sampling","volume":"32","author":"Goodman","year":"1961","journal-title":"The Annals of Mathematical Statistics"},{"issue":"2","key":"10.1016\/j.josat.2025.209633_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"The Annals of Family Medicine"},{"issue":"4","key":"10.1016\/j.josat.2025.209633_bb0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11414-020-09706-4","article-title":"Organizational facilitators and barriers to medication for opioid use disorder capacity expansion and use","volume":"47","author":"Jacobson","year":"2020","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"5","key":"10.1016\/j.josat.2025.209633_bb0155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jasp.12070","article-title":"Understanding public stigma toward substance dependence","volume":"43","author":"Janulis","year":"2013","journal-title":"Journal of Applied Social Psychology"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jrh.12260","article-title":"Medication-assisted opioid treatment prescribers in federally qualified health centers: Capacity lags in rural areas","volume":"34","author":"Jones","year":"2018","journal-title":"The Journal of Rural Health"},{"key":"10.1016\/j.josat.2025.209633_bb0165","doi-asserted-by":"crossref","first-page":"110873","DOI":"10.1016\/j.drugalcdep.2023.110873","article-title":"Understanding stigma through the lived experiences of people with opioid use disorder","volume":"249","author":"Judd","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2025.209633_bb0170","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.24847","article-title":"The effect of empathy training on the empathic skills of nurses","volume":"18","author":"Kahriman","year":"2016","journal-title":"Iranian Red Crescent Medical Journal"},{"key":"10.1016\/j.josat.2025.209633_bb0175","doi-asserted-by":"crossref","DOI":"10.1177\/21501319221112272","article-title":"Buprenorphine waiver attitudes among primary care providers","volume":"13","author":"Lai","year":"2022","journal-title":"Journal of Primary Care & Community Health"},{"issue":"3","key":"10.1016\/j.josat.2025.209633_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"2001","key":"10.1016\/j.josat.2025.209633_bb0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.soc.27.1.363","article-title":"Conceptualizing stigma","volume":"27","author":"Link","year":"2001","journal-title":"Annual Review of Sociology"},{"issue":"14","key":"10.1016\/j.josat.2025.209633_bb0190","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1080\/10826084.2021.1975749","article-title":"Intervention stigma toward medications for opioid use disorder: A systematic review","volume":"56","author":"Madden","year":"2021","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2025.209633_bb0195","doi-asserted-by":"crossref","first-page":"100161","DOI":"10.1016\/j.ssmqr.2022.100161","article-title":"Variation in intervention stigma among medications for opioid use disorder","volume":"2","author":"Madden","year":"2022","journal-title":"SSM \u2014 Qualitative Research in Health"},{"issue":"3","key":"10.1016\/j.josat.2025.209633_bb0200","doi-asserted-by":"crossref","first-page":"e223821","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Network Open"},{"issue":"Suppl. 1","key":"10.1016\/j.josat.2025.209633_bb0205","article-title":"Understanding the importance of organizational and system variables on addiction treatment services within criminal justice settings","volume":"103","author":"McCarty","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2025.209633_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab289","article-title":"A systematic review and meta-analysis of studies evaluating the effect of medication treatment for opioid use disorder on infectious disease outcomes","volume":"8","author":"McNamara","year":"2021","journal-title":"Open Forum Infectious Diseases"},{"issue":"2","key":"10.1016\/j.josat.2025.209633_bb0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/10401334.2020.1820869","article-title":"Using contact-based education to destigmatize opioid use disorder among medical students","volume":"33","author":"Mort","year":"2021","journal-title":"Teaching and Learning in Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare8010026","article-title":"The role of empathy in health and social care professionals","volume":"8","author":"Moudatsou","year":"2020","journal-title":"Healthcare"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00399-8","article-title":"\u201cThey look at us like junkies\u201d: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-017-0673-6","article-title":"Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: Findings from the SUMMIT study","volume":"18","author":"Ober","year":"2017","journal-title":"BMC Family Practice"},{"key":"10.1016\/j.josat.2025.209633_bb0235","author":"Ohio Rural Health Improvement Plan - Ohio Rural Health Association"},{"issue":"14","key":"10.1016\/j.josat.2025.209633_bb0240","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jama.2014.2147","article-title":"Confronting the stigma of opioid use disorder\u2014And its treatment","volume":"311","author":"Olsen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2025.209633_bb0245","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","article-title":"Stigma at every turn: Health services experiences among people who inject drugs","volume":"57","author":"Paquette","year":"2018","journal-title":"The International Journal on Drug Policy"},{"issue":"12","key":"10.1016\/j.josat.2025.209633_bb0250","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/add.15069","article-title":"The unique nature of public stigma toward non-medical prescription opioid use and dependence: A national study","volume":"115","author":"Perry","year":"2020","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2025.209633_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104381","article-title":"Buprenorphine dispensing before and after the April 2021 X-waiver exemptions: An interrupted time series analysis","volume":"126","author":"Roy","year":"2024","journal-title":"The International Journal on Drug Policy"},{"issue":"5","key":"10.1016\/j.josat.2025.209633_bb0265","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.5996","article-title":"Changes in US clinician waivers to prescribe buprenorphine management for opioid use disorder during the COVID-19 pandemic and after relaxation of training requirements","volume":"5","author":"Spetz","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209633_bb0270","author":"The role of Purdue Pharma and the Sackler family in the opioid epidemic"},{"key":"10.1016\/j.josat.2025.209633_bb0275","doi-asserted-by":"crossref","first-page":"103788","DOI":"10.1016\/j.drugpo.2022.103788","article-title":"Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot","volume":"107","author":"Treloar","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"10.1016\/j.josat.2025.209633_bb0280","doi-asserted-by":"crossref","first-page":"e1002969","DOI":"10.1371\/journal.pmed.1002969","article-title":"Stigma as a fundamental hindrance to the United States opioid overdose crisis response","volume":"16","author":"Tsai","year":"2019","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1016\/j.josat.2025.209633_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of OxyContin: Commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.josat.2025.209633_bb0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11606-016-3799-7","article-title":"Barriers to post-acute care for patients on opioid agonist therapy; an example of systematic stigmatization of addiction","volume":"32","author":"Wakeman","year":"2017","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1016\/j.josat.2025.209633_bb0295","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10826084.2017.1363238","article-title":"Barriers to medications for addiction treatment: How stigma kills","volume":"53","author":"Wakeman","year":"2018","journal-title":"Substance Use & Misuse"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:57:22Z","timestamp":1777323442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":58,"alternative-id":["S2949875925000128"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209633","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different forms of stigma and rural primary care professionals' willingness to prescribe buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209633"}}